Cargando…
Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma?
Anaplastic thyroid carcinoma (ATC) is a rare and aggressive form of thyroid carcinoma (TC). Currently, there are no effective treatments for this condition. In the past few years, targeted therapy and immunotherapy have made significant progress in ATC treatment. Several common genetic mutations hav...
Autores principales: | Gao, Xiaoni, Hong, Chengcheng, Xie, Yang, Zeng, Xiangtai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063970/ https://www.ncbi.nlm.nih.gov/pubmed/37007127 http://dx.doi.org/10.3389/fonc.2023.1103147 |
Ejemplares similares
-
Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017) -
Radiotherapy combined with immunotherapy successfully treated one case of anaplastic thyroid cancer: A case report
por: Xing, Yurou, et al.
Publicado: (2023) -
Combined targeted therapy and immunotherapy in anaplastic thyroid carcinoma with distant metastasis: A case report
por: Ma, Dong-Xu, et al.
Publicado: (2022) -
Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023) -
Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management
por: Yuan, Jiaqian, et al.
Publicado: (2022)